Phase 4 Rheumatoid Arthritis Trial, Recruiting NCT06906549 Sponsor: University Hospital, Strasbourg, France Condition: Rheumatoid Arthritis
Back to Rheumatoid Arthritis

Phase 4 Rheumatoid Arthritis Trial, Recruiting

NCT06906549
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with rheumatoid arthritis (RA) based on recognised medical classification guidelines
  • Your rheumatoid arthritis disease activity is at a moderate level or below, based on a standard scoring system called DAS28 (confirm with trial site)
  • You are currently being treated with a medication called Rituximab, and you have already completed at least your first course of treatment (two initial infusions)
  • Your last Rituximab infusion was between 6 and 18 months before joining the trial
  • If you take steroid medication (such as prednisone), you are taking no more than 10 mg per day in the 4 weeks before joining
  • You are covered by a social insurance or healthcare system
  • You are willing and able to sign a written consent form before the trial begins
  • You are using an effective form of birth control for the duration of the study

Who may not be able to join:

  • You have another autoimmune rheumatic disease in addition to RA (having Sjögren's disease alongside RA is acceptable)
  • You are currently taking another targeted biological or specialist medication alongside Rituximab
  • You have a known medical reason why you cannot receive Rituximab or a saline (saltwater) solution
  • You have another significant medical condition that is not well controlled
  • You have a known active infection, or a history of serious, repeated, or long-term infections
  • Your blood test results show untreated tuberculosis, hepatitis B or C, low red blood cell levels, low white blood cell levels, or low levels of certain immune proteins (confirm with trial site)
  • You are pregnant, breastfeeding, or planning to become pregnant during the study
  • You have a current addiction to drugs or alcohol
  • You are not able to attend follow-up appointments for the full 12 months of the study
  • You are an adult who is legally under protection or whose freedom is restricted by a court or official decision
  • You are currently taking part in, or are in an exclusion period from, another clinical trial
  • You are unable to give informed consent — for example, due to a medical emergency or difficulty understanding the details of the trial
  • You have difficulty reading, understanding, or communicating in French

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
11 July 2025
Est. completion
1 July 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Mean reduction of rheumatoid arthritis activity score (DAS28-CRP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov